147 related articles for article (PubMed ID: 35175401)
1. [Prognosis after resection of intrahepatic cholangiocarcinoma: clinical significance of KRAS mutations].
Schneider MA; Büchler MW
Chirurg; 2022 Mar; 93(3):306-307. PubMed ID: 35175401
[No Abstract] [Full Text] [Related]
2. Correlation between KRAS gene mutations and linicopathological features of patients with intrahepatic cholangiocarcinoma.
Wang J; Xu MX; Wang LQ; Li HY; Wang ZL; Li LJ
J Biol Regul Homeost Agents; 2019; 33(5):1551-1557. PubMed ID: 31635679
[No Abstract] [Full Text] [Related]
3. KRAS mutation in intrahepatic cholangiocarcinoma: Linkage with metastasis-free survival and reduced E-cadherin expression.
Tanaka M; Kunita A; Yamagishi M; Katoh H; Ishikawa S; Yamamoto H; Abe J; Arita J; Hasegawa K; Shibata T; Ushiku T
Liver Int; 2022 Oct; 42(10):2329-2340. PubMed ID: 35833881
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis on prognostic value of KRAS mutation in resected mass-forming cholangiocarcinoma.
Procopio F; Branciforte B; Nappo G; Di Tommaso L; Lleo A; Torzilli G
Eur J Surg Oncol; 2022 Jul; 48(7):1455-1463. PubMed ID: 35317947
[TBL] [Abstract][Full Text] [Related]
5. Association of KRAS Variant Subtypes With Survival and Recurrence in Patients With Surgically Treated Intrahepatic Cholangiocarcinoma.
Zhou SL; Xin HY; Sun RQ; Zhou ZJ; Hu ZQ; Luo CB; Wang PC; Li J; Fan J; Zhou J
JAMA Surg; 2022 Jan; 157(1):59-65. PubMed ID: 34730772
[TBL] [Abstract][Full Text] [Related]
6. Genetic Determinants of Outcome in Intrahepatic Cholangiocarcinoma.
Boerner T; Drill E; Pak LM; Nguyen B; Sigel CS; Doussot A; Shin P; Goldman DA; Gonen M; Allen PJ; Balachandran VP; Cercek A; Harding J; Solit DB; Schultz N; Kundra R; Walch H; D'Angelica MI; DeMatteo RP; Drebin J; Kemeny NE; Kingham TP; Simpson AL; Hechtman JF; Vakiani E; Lowery MA; Ijzermans JNM; Buettner S; Koerkamp BG; Doukas M; Chandwani R; Jarnagin WR
Hepatology; 2021 Sep; 74(3):1429-1444. PubMed ID: 33765338
[TBL] [Abstract][Full Text] [Related]
7. MDM2 Amplification in Intrahepatic Cholangiocarcinomas: Its Relationship With Large-Duct Type Morphology and Uncommon KRAS Mutations.
Kim SJ; Akita M; Sung YN; Fujikura K; Lee JH; Hwang S; Yu E; Otani K; Hong SM; Zen Y
Am J Surg Pathol; 2018 Apr; 42(4):512-521. PubMed ID: 29309301
[TBL] [Abstract][Full Text] [Related]
8. Mutation analysis and copy number changes of KRAS and BRAF genes in Taiwanese cases of biliary tract cholangiocarcinoma.
Huang WC; Tsai CC; Chan CC
J Formos Med Assoc; 2017 Jun; 116(6):464-468. PubMed ID: 27745798
[TBL] [Abstract][Full Text] [Related]
9. Anatomical, histomorphological and molecular classification of cholangiocarcinoma.
Kendall T; Verheij J; Gaudio E; Evert M; Guido M; Goeppert B; Carpino G
Liver Int; 2019 May; 39 Suppl 1():7-18. PubMed ID: 30882996
[TBL] [Abstract][Full Text] [Related]
10. Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients.
Ruzzenente A; Fassan M; Conci S; Simbolo M; Lawlor RT; Pedrazzani C; Capelli P; D'Onofrio M; Iacono C; Scarpa A; Guglielmi A
Ann Surg Oncol; 2016 May; 23(5):1699-707. PubMed ID: 26717940
[TBL] [Abstract][Full Text] [Related]
11. Protein expression and genetic alterations of p53 and ras in intrahepatic cholangiocarcinoma.
Furubo S; Harada K; Shimonishi T; Katayanagi K; Tsui W; Nakanuma Y
Histopathology; 1999 Sep; 35(3):230-40. PubMed ID: 10469215
[TBL] [Abstract][Full Text] [Related]
12. De novo somatic mutations and KRAS amplification are associated with cholangiocarcinoma in a patient with a history of choledochal cyst.
Schwab ME; Song H; Mattis A; Phelps A; Vu LT; Huang FW; Nijagal A
J Pediatr Surg; 2020 Dec; 55(12):2657-2661. PubMed ID: 32295706
[TBL] [Abstract][Full Text] [Related]
13. K-ras mutation is strongly associated with perineural invasion and represents an independent prognostic factor of intrahepatic cholangiocarcinoma after hepatectomy.
Chen TC; Jan YY; Yeh TS
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S675-81. PubMed ID: 22805857
[TBL] [Abstract][Full Text] [Related]
14. Integrative analysis of KRAS wildtype metastatic pancreatic ductal adenocarcinoma reveals mutation and expression-based similarities to cholangiocarcinoma.
Topham JT; Tsang ES; Karasinska JM; Metcalfe A; Ali H; Kalloger SE; Csizmok V; Williamson LM; Titmuss E; Nielsen K; Negri GL; Spencer Miko SE; Jang GH; Denroche RE; Wong HL; O'Kane GM; Moore RA; Mungall AJ; Loree JM; Notta F; Wilson JM; Bathe OF; Tang PA; Goodwin R; Morin GB; Knox JJ; Gallinger S; Laskin J; Marra MA; Jones SJM; Schaeffer DF; Renouf DJ
Nat Commun; 2022 Oct; 13(1):5941. PubMed ID: 36209277
[TBL] [Abstract][Full Text] [Related]
15. Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors.
Andersen JB; Spee B; Blechacz BR; Avital I; Komuta M; Barbour A; Conner EA; Gillen MC; Roskams T; Roberts LR; Factor VM; Thorgeirsson SS
Gastroenterology; 2012 Apr; 142(4):1021-1031.e15. PubMed ID: 22178589
[TBL] [Abstract][Full Text] [Related]
16. Utility of KRAS mutational analysis in the preoperative diagnosis of synchronous pancreatic cancer and intrahepatic cholangiocarcinoma: A case report.
Eso Y; Uza N; Yamagishi H; Imada K; Kimura Y; Masui T; Kodama Y; Seno H
Medicine (Baltimore); 2017 Dec; 96(50):e9217. PubMed ID: 29390348
[TBL] [Abstract][Full Text] [Related]
17. [Metachronous cancer of common bile duct after resection of an intrahepatic cholangiocarcinoma].
Duriez A; Truant S; Desurmont P; Sergent G; Buob D; Leteurtre E; Zerbib P; Pruvot FR; Maunoury V
Gastroenterol Clin Biol; 2010 Feb; 34(2):115-6. PubMed ID: 20071114
[No Abstract] [Full Text] [Related]
18. The prognosis of perihilar cholangiocarcinoma after radical treatments.
Fabris L; Alvaro D
Hepatology; 2012 Sep; 56(3):800-2. PubMed ID: 22532318
[No Abstract] [Full Text] [Related]
19. Intrahepatic mucinous cholangiocarcinoma.
Lin BY; Wu CC; Tsai TH
Kaohsiung J Med Sci; 2020 Sep; 36(9):757-758. PubMed ID: 32492241
[No Abstract] [Full Text] [Related]
20. Results of resection for hilar cholangiocarcinoma with analysis of prognostic factors.
Havlik R; Sbisà E; Tullo A; Kelly MD; Mitry RR; Jiao LR; Mansour MR; Honda K; Habib NA
Hepatogastroenterology; 2000; 47(34):927-31. PubMed ID: 11020850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
